• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种生成生物监测当量分布以支持暴露评估和优先级排序的新方法。

A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.

作者信息

Phillips Martin B, Sobus Jon R, George Barbara J, Isaacs Kristin, Conolly Rory, Tan Yu-Mei

机构信息

U.S. Environmental Protection Agency, National Exposure Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA.

U.S. Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, 109 TW Alexander Dr, Research Triangle Park, NC 27709, USA.

出版信息

Regul Toxicol Pharmacol. 2014 Aug;69(3):434-42. doi: 10.1016/j.yrtph.2014.05.008. Epub 2014 May 17.

DOI:10.1016/j.yrtph.2014.05.008
PMID:24845241
Abstract

Biomonitoring data are now available for hundreds of chemicals through state and national health surveys. Exposure guidance values also exist for many of these chemicals. Several methods are frequently used to evaluate biomarker data with respect to a guidance value. The "biomonitoring equivalent" (BE) approach estimates a single biomarker concentration (called the BE) that corresponds to a guidance value (e.g., Maximum Contaminant Level, Reference Dose, etc.), which can then be compared with measured biomarker data. The resulting "hazard quotient" estimates (HQ=biomarker concentration/BE) can then be used to prioritize chemicals for follow-up examinations. This approach is used exclusively for population-level assessments, and works best when the central tendency of measurement data is considered. Complementary approaches are therefore needed for assessing individual biomarker levels, particularly those that fall within the upper percentiles of measurement distributions. In this case study, probabilistic models were first used to generate distributions of BEs for perchlorate based on the point-of-departure (POD) of 7μg/kg/day. These distributions reflect possible biomarker concentrations in a hypothetical population where all individuals are exposed at the POD. A statistical analysis was then performed to evaluate urinary perchlorate measurements from adults in the 2001 to 2002 National Health and Nutrition Examination Survey (NHANES). Each NHANES adult was assumed to have experienced repeated exposure at the POD, and their biomarker concentration was interpreted probabilistically with respect to a BE distribution. The HQ based on the geometric mean (GM) urinary perchlorate concentration was estimated to be much lower than unity (HQ≈0.07). This result suggests that the average NHANES adult was exposed to perchlorate at a level well below the POD. Regarding individuals, at least a 99.8% probability was calculated for all but two NHANES adults that a higher biomarker concentration would have been observed compared to what was actually measured if the daily dietary exposure had been at the POD. This is strong evidence that individual perchlorate exposures in the 2001-2002 NHANES adult population were likely well below the POD. This case study demonstrates that the "stochastic BE approach" provides useful quantitative metrics, in addition to HQ estimates, for comparison across chemicals. This methodology should be considered when evaluating biomarker measurements against exposure guidance values, and when examining chemicals that have been identified as needing follow-up investigation based on existing HQ estimates.

摘要

通过州和国家健康调查,现在可以获得数百种化学品的生物监测数据。许多此类化学品也有暴露指导值。经常使用几种方法来根据指导值评估生物标志物数据。“生物监测当量”(BE)方法估计一个与指导值(例如,最大污染物水平、参考剂量等)相对应的单一生物标志物浓度(称为BE),然后可以将其与实测生物标志物数据进行比较。由此得出的“危害商数”估计值(HQ = 生物标志物浓度/BE)可用于对化学品进行优先排序,以便进行后续检查。这种方法专门用于人群水平的评估,在考虑测量数据的中心趋势时效果最佳。因此,需要补充方法来评估个体生物标志物水平,特别是那些落在测量分布较高百分位数范围内的水平。在本案例研究中,首先使用概率模型根据7μg/kg/天的起始点(POD)生成高氯酸盐的BE分布。这些分布反映了假设人群中所有个体都以POD暴露时可能的生物标志物浓度。然后进行统计分析,以评估2001年至2002年国家健康与营养检查调查(NHANES)中成年人的尿高氯酸盐测量值。假设每个NHANES成年人都在POD下经历了重复暴露,并根据BE分布对其生物标志物浓度进行概率解释。基于几何平均(GM)尿高氯酸盐浓度的HQ估计值远低于1(HQ≈0.07)。这一结果表明,NHANES成年人的平均高氯酸盐暴露水平远低于POD。就个体而言,对于除两名NHANES成年人之外的所有人,计算出如果每日饮食暴露处于POD水平,与实际测量值相比,观察到更高生物标志物浓度的概率至少为99.8%。这有力地证明了2001 - 2002年NHANES成年人群体中个体的高氯酸盐暴露可能远低于POD。本案例研究表明,“随机BE方法”除了HQ估计值之外,还提供了有用的定量指标,用于跨化学品进行比较。在根据暴露指导值评估生物标志物测量值以及检查已根据现有HQ估计值确定需要进行后续调查的化学品时,应考虑这种方法。

相似文献

1
A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.一种生成生物监测当量分布以支持暴露评估和优先级排序的新方法。
Regul Toxicol Pharmacol. 2014 Aug;69(3):434-42. doi: 10.1016/j.yrtph.2014.05.008. Epub 2014 May 17.
2
Temporal trends in bisphenol A exposure in the United States from 2003-2012 and factors associated with BPA exposure: Spot samples and urine dilution complicate data interpretation.2003年至2012年美国双酚A暴露的时间趋势以及与双酚A暴露相关的因素:即时样本和尿液稀释使数据解读复杂化。
Environ Res. 2015 Oct;142:84-95. doi: 10.1016/j.envres.2015.06.013. Epub 2015 Jun 26.
3
Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data.解读2,4-二氯苯氧乙酸的生物监测数据:生物监测当量及人群生物监测数据的更新
Regul Toxicol Pharmacol. 2015 Dec;73(3):765-9. doi: 10.1016/j.yrtph.2015.11.001. Epub 2015 Nov 12.
4
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria.评估 NHANES 血液中挥发性有机化学物质的生物监测数据:应用化学特异性筛选标准。
J Expo Sci Environ Epidemiol. 2012 Jan-Feb;22(1):24-34. doi: 10.1038/jes.2011.37. Epub 2011 Oct 12.
5
Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.在基于风险的背景下筛选加拿大健康措施调查中的人群水平生物监测数据。
Toxicol Lett. 2014 Dec 1;231(2):126-34. doi: 10.1016/j.toxlet.2014.10.019. Epub 2014 Oct 17.
6
Using a physiologically based pharmacokinetic model to link urinary biomarker concentrations to dietary exposure of perchlorate.利用生理基于药代动力学模型将尿生物标志物浓度与高氯酸盐的饮食暴露联系起来。
Chemosphere. 2012 Aug;88(8):1019-27. doi: 10.1016/j.chemosphere.2012.03.074. Epub 2012 Apr 20.
7
Environmental chemicals in people: challenges in interpreting biomonitoring information.人体中的环境化学物质:解读生物监测信息面临的挑战。
J Environ Health. 2008 May;70(9):61-4.
8
Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.人体生物监测作为支持化学品健康风险管理的实用工具——以欧盟 REACH 计划为例。
Regul Toxicol Pharmacol. 2011 Feb;59(1):125-32. doi: 10.1016/j.yrtph.2010.09.015. Epub 2010 Oct 7.
9
Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.化学特异性筛选标准用于解释挥发性有机化合物(VOCs)生物监测数据 - 稳态 PBPK 模型解决方案的应用。
Regul Toxicol Pharmacol. 2010 Oct;58(1):33-44. doi: 10.1016/j.yrtph.2010.05.011. Epub 2010 Jun 1.
10
California biomonitoring data: Comparison to NHANES and interpretation in a risk assessment context.加利福尼亚生物监测数据:与美国国家健康与营养检查调查(NHANES)的比较及在风险评估背景下的解读
Regul Toxicol Pharmacol. 2015 Dec;73(3):875-84. doi: 10.1016/j.yrtph.2015.10.002. Epub 2015 Oct 23.

引用本文的文献

1
Reducing uncertainty in dose-response assessments by incorporating Bayesian benchmark dose modeling and in vitro data on population variability.通过纳入贝叶斯基准剂量模型和关于群体变异性的体外数据来降低剂量反应评估中的不确定性。
Risk Anal. 2025 Feb;45(2):457-472. doi: 10.1111/risa.17451. Epub 2024 Aug 16.
2
Uses of NHANES Biomarker Data for Chemical Risk Assessment: Trends, Challenges, and Opportunities.美国国家健康与营养检查调查(NHANES)生物标志物数据在化学物质风险评估中的应用:趋势、挑战与机遇
Environ Health Perspect. 2015 Oct;123(10):919-27. doi: 10.1289/ehp.1409177. Epub 2015 Apr 10.
3
Analysis of biomarker utility using a PBPK/PD model for carbaryl.
使用针对西维因的生理药代动力学/药效学(PBPK/PD)模型分析生物标志物的效用。
Front Pharmacol. 2014 Nov 18;5:246. doi: 10.3389/fphar.2014.00246. eCollection 2014.